%0 Journal Article
%T Incidence rates of progressive childhood encephalopathy in Oslo, Norway: a population based study
%A Petter Stromme
%A Oivind Kanavin
%A Michael Abdelnoor
%A Berit Woldseth
%A Terje Rootwelt
%A Jorgen Diderichsen
%A Bjorn Bjurulf
%A Finn Sommer
%A Per Magnus
%J BMC Pediatrics
%D 2007
%I BioMed Central
%R 10.1186/1471-2431-7-25
%X We included PE cases born between 1985 and 2003, living in Oslo, and registered the number presenting annually between 1985 and 2004. Person-years at risk between 0 and 15 years were based on the number of live births during the observation period which was divided into four 5-year intervals. We calculated incidence rates according to age at onset which was classified as neonatal (0每4 weeks), infantile (1每12 months), late infantile (1每5 years), and juvenile (6每12 years).We found 84 PE cases representing 28 diagnoses among 1,305,997 person years, giving an incidence rate of 6.43 per 100,000 person years. The age-specific incidence rates per 100,000 were: 79.89 (<1 year), 8.64 (1每2 years), 1.90 (2每5 years), and 0.65 (>5 years). 66% (55/84) of the cases were metabolic, 32% (27/54) were neurodegenerative, and 2% (2/84) had HIV encephalopathy. 71% (60/84) of the cases presented at < 1 year, 24% (20/84) were late infantile presentations, and 5% (4/84) were juvenile presentations. Neonatal onset was more common in the metabolic (46%) (25/55) compared to the neurodegenerative group (7%) (2/27). 20% (17/84) of all cases were classified as unspecified neurodegenerative disease.The overall incidence rate of PE was 6.43 per 100,000 person years. There was a strong reduction in incidence rates with increasing age. Two-thirds of the cases were metabolic, of which almost half presented in the neonatal period.Progressive neurological disease in children poses an important challenge to our health system in terms of diagnosis and management [1-3]. In the present study, we focused on children presenting with signs of progressive CNS disease associated with impairment of cognitive functioning, designated progressive encephalopathy (PE). In the literature, PE is often used interchangeably with neurodegenerative encephalopathy. Both terms lack a firm definition, but we preferred PE because it encompasses clinically progressive conditions without demonstrable neuronal loss as well as thos
%U http://www.biomedcentral.com/1471-2431/7/25